Brain scan study tests drug for dementia mood symptoms
NCT ID NCT06604520
Summary
This study is testing if a medication called vortioxetine can help improve mood symptoms like depression and anxiety, as well as thinking skills, in people with early-stage behavioral variant frontotemporal dementia (bvFTD). Researchers will give participants the drug for 12 weeks and use brain scans and memory tests to see if it helps. The goal is to see if this treatment can ease some of the difficult symptoms of this type of dementia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.